Trump Admin Hands Bill Gates’ GAVI Vaccine Syndicate $600 Million

“Achieving these transitions will require manufacturers to expand production capacity,” State Department says

This post was published by Jon Fleetwood. Support him by subscribing at Substack and following at Instagram / X / Facebook.

The U.S. Department of State and U.S. Department of Health and Human Services last month revealed they “will immediately release all $600 million in Congressionally appropriated funds” for Gavi, the Vaccine Alliance, Bill Gates’ international vaccine syndicate, according to a State Department press release.

In June 2025, HHS Secretary Robert F. Kennedy Jr. had withdrawn American funding from Gavi, citing child deaths linked to the vaccines the organization dispenses worldwide.

But one year later, Secretary of State Marco Rubio promised that the United States would “re-engage” with Gavi, citing a purported Ebola outbreak as justification.

The new State Department press release emphasizes President Donald Trump gave the directive himself.

Per the release:

“Last year, President Trump directed Secretary of Health and Human Services Robert F. Kennedy, Jr. and Secretary of State Marco Rubio to engage directly with Gavi, the Vaccine Alliance (Gavi), and secure meaningful reforms before the United States would consider future support. Those discussions resulted in significant commitments that strengthen vaccine safety, improve public health, and better align Gavi’s work with the principles of Gold Standard Science and transparency. Based on those commitments, the United States will immediately release all $600 million in Congressionally appropriated funds to Gavi for both FY25 and FY26.”

The agreement included “reducing reliance on mercury-containing vaccines, where suitable alternatives are available.”

The release didn’t specify which alternatives would be used nor cite any relevant safety studies.

But it did confirm vaccine manufacturers would benefit:

“Achieving these transitions will require manufacturers to expand production capacity, countries to adopt newer vaccine formulations, and Gavi’s governing Board to complete the necessary approvals. The United States recognizes these implementation challenges but welcomes Gavi’s commitment to work toward these goals through transparent governance and responsible stewardship.”

The Trump admin ultimately wants to “resume its place on the Gavi Board”:

“In addition, given the sizeable contribution the United States is making to improve access to vaccines, the United States expects to resume its place on the Gavi Board. In this role, the United States will continue to hold Gavi accountable for measurable progress toward these commitments. It will evaluate any future U.S. support based on demonstrated performance, accountability, and implementation of these reforms.”

Your support is crucial in helping us defeat mass censorship. Please consider donating via Locals or check out our unique merch. Follow us on X @ModernityNews.


More news on our radar


Share this article
Shareable URL

Leave a Reply.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0
Share